|
|
- 2019
A comparison of long-term healthcare utilization and costs in patients with acute severe ulcerative colitis receiving infliximab versus early colectomyKeywords: biologics, health economics, inflammatory bowel disease, outcomes research, surgery, ulcerative colitis Abstract: Early intervention for acute severe ulcerative colitis (ASUC) improves outcomes. Outcomes and healthcare costs for an infliximab-first and colectomy-first approach were compared
|
